Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>


Close X


Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more

Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Jay Knight Comments on President-elect Trump's New SEC Appointment

Compliance Week

Media Mentions

January 11, 2017

In an article published by Compliance Week, Bass, Berry & Sims attorney Jay Knight provided insight on the newly appointed U.S. Securities and Exchange Commission (SEC) chairman, Jay Clayton of Sullivan & Cromwell. Clayton is a respected expert in mergers, acquisitions and capital formation but has some controversy surrounding his view on the Foreign Corrupt Practices Act (FCPA). Knight is encouraged by the nomination as he believes that Clayton's skill set fits well with the SEC's capital formation and investor protection efforts. Knight believes that Clayton's experience in M&A deals can be applied as chairman by being able to understand marketplace issues. "This is somebody who is very familiar with the SEC's mission," said Knight in the article.

The full article, "What to Expect from Trump's SEC Nomination," was published by Compliance Week on January 10, 2017, and is available online.

Visit our Securities Law Exchange blog to read our recent post detailing Clayton's experience and additional media reaction to his appointment, "Quick Fact Sheet on Trump’s Pick for SEC Chair."

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.